Previous 10 | Next 10 |
Analysis of the top ten pharma and medical device companies shows a 2% advantage for medical device on a total return basis over the last ten years. There are many possible reasons for this difference but patent cliffs and litigation are problems for Pharma. Investors seeking supe...
Yacktman's 13F equity portfolio value decreased from $11.21B to $9.64B this quarter. Yacktman Asset Management added Warner Bros. Discovery and Embecta Corp. while decreasing Sysco Corporation and Coca-Cola Company. Yacktman’s largest five stakes are at ~31% of the portfoli...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Becton Dickinson and Co (BDX) Q3 2022 Earnings Conference Call August 04, 2022, 08:00 ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP, Pre...
Shares of Becton, Dickinson ( NYSE: BDX ), or BD, added as much as 4.7% to $256.41 in Thursday morning trading, after the medical device and health equipment maker reported Q3 results that beat estimates and upped its FY 2022 guidance. BDX stock had pared some of the gai...
Becton, Dickinson press release ( NYSE: BDX ): Q2 Non-GAAP EPS of $2.66 beats by $0.16 . Revenue of $4.64B (+0.7% Y/Y) beats by $170M . Revenue from continuing operations driven by base revenue growth of 6.0% as reported, 9.3% currency-neutral Worldwide COV...
BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS PR Newswire Revenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basis Revenue from continuing operations driven by base revenue growth of 6.0% as repor...
William von Mueffling's 13F portfolio value decreased this quarter from $14.01B to $11.98B. Cantillon increased Microsoft, BlackRock, Interactive Brokers, and Endeavor Group Holdings during the quarter. They also added Adobe Systems and Hayward Holdings. The portfolio continues to...
Becton, Dickinson and Company is one of my favorite dividend growth investments. I am constantly looking for opportunities to add to my position. Despite the market volatility and the challenging environment, Becton, Dickinson and Company is not attractively valued. Intr...
A quickly changing interest rate environment, growing fears of a recession and geopolitical uncertainty made for a volatile second quarter of 2022. Companies with stable, predictable cash flows led contributors as risks to global economic growth mounted. ClearBridge engagements wi...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...